Global Chemosynthetic Polypeptide Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 12608

Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly because of the therapeutic and curative effects it offers. Their prime areas of application are curing of diseases like tumor, metabolism, immunoregulation, cardiovascular diseases, and various other infectious diseases. These chemosynthetic polypeptide drugs are much more influential as compared to the traditional drugs, hence will likely replace the existing pharmaceutical drugs. Currently, there are more than 140 polypeptide drugs available in the global market. Some of the major chemosynthetic polypeptide drugs available in the global market are thymalfasin, thymopentin, somatostatin, octreotide and thyrocalcitonin.
Chemosynthetic polypeptide drugs market has expanded tremendously over the last decade. Major driving factors for the growth of the chemosynthetic polypeptide drugs market, include, increasing need to expand the development of new drugs due to rising number of cancer patients and metabolic diseases like diabetes, and increased government funding for the development of novel drugs. All these factors have fostered towards increasing research and development in the chemosynthetic polypeptide drugs market.

The global Chemosynthetic Polypeptide Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chemosynthetic Polypeptide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chemosynthetic Polypeptide Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Peptides International
Biovectra
X-Gen Pharmaceuticals
Eli Lilly
F.Hoffmann-La Roche
Amylin Pharmaceuticals
Novo-Nordisk
Amgen
Ipsen

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Vasopressin
Bacitracin
Icatibant
Colistin (Polymyxin E) And Polymyxin B
Colistin Methane Sulfonate

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

Table of Contents

Executive Summary
1 Chemosynthetic Polypeptide Drugs Market Overview
1.1 Product Overview and Scope of Chemosynthetic Polypeptide Drugs
1.2 Chemosynthetic Polypeptide Drugs Segment by Type
1.2.1 Global Chemosynthetic Polypeptide Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Vasopressin
1.2.3 Bacitracin
1.2.4 Icatibant
1.2.5 Colistin (Polymyxin E) And Polymyxin B
1.2.6 Colistin Methane Sulfonate
1.3 Chemosynthetic Polypeptide Drugs Segment by Application
1.3.1 Chemosynthetic Polypeptide Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Chemosynthetic Polypeptide Drugs Market by Region
1.4.1 Global Chemosynthetic Polypeptide Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Chemosynthetic Polypeptide Drugs Market Size
1.5.1 Global Chemosynthetic Polypeptide Drugs Revenue (2014-2025)
1.5.2 Global Chemosynthetic Polypeptide Drugs Production (2014-2025)

2 Global Chemosynthetic Polypeptide Drugs Market Competition by Manufacturers
2.1 Global Chemosynthetic Polypeptide Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Chemosynthetic Polypeptide Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Chemosynthetic Polypeptide Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Chemosynthetic Polypeptide Drugs Production Sites, Area Served, Product Types
2.5 Chemosynthetic Polypeptide Drugs Market Competitive Situation and Trends
2.5.1 Chemosynthetic Polypeptide Drugs Market Concentration Rate
2.5.2 Chemosynthetic Polypeptide Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Chemosynthetic Polypeptide Drugs Production Market Share by Regions
3.1 Global Chemosynthetic Polypeptide Drugs Production Market Share by Regions
3.2 Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Chemosynthetic Polypeptide Drugs Production
3.4.1 North America Chemosynthetic Polypeptide Drugs Production Growth Rate (2014-2019)
3.4.2 North America Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Chemosynthetic Polypeptide Drugs Production
3.5.1 Europe Chemosynthetic Polypeptide Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Chemosynthetic Polypeptide Drugs Production (2014-2019)
3.6.1 China Chemosynthetic Polypeptide Drugs Production Growth Rate (2014-2019)
3.6.2 China Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Chemosynthetic Polypeptide Drugs Production (2014-2019)
3.7.1 Japan Chemosynthetic Polypeptide Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Chemosynthetic Polypeptide Drugs Consumption by Regions
4.1 Global Chemosynthetic Polypeptide Drugs Consumption by Regions
4.2 North America Chemosynthetic Polypeptide Drugs Consumption (2014-2019)
4.3 Europe Chemosynthetic Polypeptide Drugs Consumption (2014-2019)
4.4 China Chemosynthetic Polypeptide Drugs Consumption (2014-2019)
4.5 Japan Chemosynthetic Polypeptide Drugs Consumption (2014-2019)

5 Global Chemosynthetic Polypeptide Drugs Production, Revenue, Price Trend by Type
5.1 Global Chemosynthetic Polypeptide Drugs Production Market Share by Type (2014-2019)
5.2 Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Chemosynthetic Polypeptide Drugs Price by Type (2014-2019)
5.4 Global Chemosynthetic Polypeptide Drugs Production Growth by Type (2014-2019)

6 Global Chemosynthetic Polypeptide Drugs Market Analysis by Applications
6.1 Global Chemosynthetic Polypeptide Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Chemosynthetic Polypeptide Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Chemosynthetic Polypeptide Drugs Business
7.1 Peptides International
7.1.1 Peptides International Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.1.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.1.3 Peptides International Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Biovectra
7.2.1 Biovectra Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.2.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.2.3 Biovectra Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 X-Gen Pharmaceuticals
7.3.1 X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.3.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.3.3 X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Eli Lilly
7.4.1 Eli Lilly Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.4.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.4.3 Eli Lilly Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 F.Hoffmann-La Roche
7.5.1 F.Hoffmann-La Roche Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.5.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.5.3 F.Hoffmann-La Roche Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Amylin Pharmaceuticals
7.6.1 Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.6.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.6.3 Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Novo-Nordisk
7.7.1 Novo-Nordisk Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.7.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.7.3 Novo-Nordisk Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Amgen
7.8.1 Amgen Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.8.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.8.3 Amgen Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Ipsen
7.9.1 Ipsen Chemosynthetic Polypeptide Drugs Production Sites and Area Served
7.9.2 Chemosynthetic Polypeptide Drugs Product Introduction, Application and Specification
7.9.3 Ipsen Chemosynthetic Polypeptide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served

8 Chemosynthetic Polypeptide Drugs Manufacturing Cost Analysis
8.1 Chemosynthetic Polypeptide Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Chemosynthetic Polypeptide Drugs
8.4 Chemosynthetic Polypeptide Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Chemosynthetic Polypeptide Drugs Distributors List
9.3 Chemosynthetic Polypeptide Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Chemosynthetic Polypeptide Drugs Market Forecast
11.1 Global Chemosynthetic Polypeptide Drugs Production, Revenue Forecast
11.1.1 Global Chemosynthetic Polypeptide Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Chemosynthetic Polypeptide Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Chemosynthetic Polypeptide Drugs Price and Trend Forecast (2019-2025)
11.2 Global Chemosynthetic Polypeptide Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Chemosynthetic Polypeptide Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Chemosynthetic Polypeptide Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Chemosynthetic Polypeptide Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Chemosynthetic Polypeptide Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Chemosynthetic Polypeptide Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Chemosynthetic Polypeptide Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Chemosynthetic Polypeptide Drugs Consumption Forecast (2019-2025)
11.3.3 China Chemosynthetic Polypeptide Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Chemosynthetic Polypeptide Drugs Consumption Forecast (2019-2025)
11.4 Global Chemosynthetic Polypeptide Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Chemosynthetic Polypeptide Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer